Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Daiichi Sankyo at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Daiichi Sankyo brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 1939. Its program centres on acute myeloid leukemia. It supports a case-review symposium on AML management and presents research on quizartinib and heart rhythm.

OrganizationASH 2026 Attendance
Daiichi Sankyo
Tokyo, Japan
Large pharma
Japanese pharmaceutical company with around 16,000 employees in over 20 countries, whose oncology medicines include antibody-drug conjugates.
Booth
Exhibiting at Booth 1939
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00am–10:00am
Current Management Paradigms in Acute Myeloid Leukemia – A Second Opinion Case Review
Difficult acute myeloid leukemia cases where doctors sought second opinions, paired with reviews of recent data, current management, and ongoing trials.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Daiichi Sankyo

Tell us what you sell and we’ll find the people at Daiichi Sankyo most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction